In order to identify potential prognostic factors affecting the outcomes of AML patients bearing the FLT3-ITD mutation only (Group 3), a multivariate analysis for EFS and OS was performed for the Group 3 of 50 patients (NPM1wt/FLT3-ITD) with AML. The gene discussed is FLT3; the disease is acute myeloid leukemia.